These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30878699)

  • 1. T-Cell mediated adaptive immunity and antibody-dependent enhancement in secondary dengue infection.
    Sasmal SK; Takeuchi Y; Nakaoka S
    J Theor Biol; 2019 Jun; 470():50-63. PubMed ID: 30878699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling original antigenic sin in dengue viral infection.
    Nikin-Beers R; Ciupe SM
    Math Med Biol; 2018 Jun; 35(2):257-272. PubMed ID: 28339786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection severity across scales in multi-strain immuno-epidemiological Dengue model structured by host antibody level.
    Gulbudak H; Browne CJ
    J Math Biol; 2020 May; 80(6):1803-1843. PubMed ID: 32157381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
    Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus antibody dynamics in primary and secondary dengue infections.
    Gujarati TP; Ambika G
    J Math Biol; 2014 Dec; 69(6-7):1773-800. PubMed ID: 24384697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stochastic Model of the Adaptive Immune Response Predicts Disease Severity and Captures Enhanced Cross-Reactivity in Natural Dengue Infections.
    Nguyen HD; Chaudhury S; Waickman AT; Friberg H; Currier JR; Wallqvist A
    Front Immunol; 2021; 12():696755. PubMed ID: 34484195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune correlates for dengue vaccine development.
    Srikiatkhachorn A; Yoon IK
    Expert Rev Vaccines; 2016; 15(4):455-65. PubMed ID: 26560015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antibodies in controlling dengue virus infection.
    van der Schaar HM; Wilschut JC; Smit JM
    Immunobiology; 2009; 214(7):613-29. PubMed ID: 19261353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model for studying dengue virus pathogenesis and immune response.
    Williams KL; Zompi S; Beatty PR; Harris E
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E12-23. PubMed ID: 19751398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
    Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
    J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis.
    Gan ES; Ting DH; Chan KR
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):111-119. PubMed ID: 27796143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.
    Fink J; Gu F; Vasudevan SG
    Rev Med Virol; 2006; 16(4):263-75. PubMed ID: 16791836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of cellular immune responses in the acute phase of dengue virus infection.
    Yoshida T; Omatsu T; Saito A; Katakai Y; Iwasaki Y; Kurosawa T; Hamano M; Higashino A; Nakamura S; Takasaki T; Yasutomi Y; Kurane I; Akari H
    Arch Virol; 2013 Jun; 158(6):1209-20. PubMed ID: 23381396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell immunity to dengue virus and implications for vaccine design.
    Rivino L
    Expert Rev Vaccines; 2016; 15(4):443-53. PubMed ID: 26560171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
    Xu M; Züst R; Toh YX; Pfaff JM; Kahle KM; Davidson E; Doranz BJ; Velumani S; Tukijan F; Wang CI; Fink K
    J Virol; 2016 Dec; 90(24):11122-11131. PubMed ID: 27707930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical modeling on T-cell mediated adaptive immunity in primary dengue infections.
    Sasmal SK; Dong Y; Takeuchi Y
    J Theor Biol; 2017 Sep; 429():229-240. PubMed ID: 28684293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.
    Chaudhury S; Gromowski GD; Ripoll DR; Khavrutskii IV; Desai V; Wallqvist A
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005395. PubMed ID: 28222130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.
    Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS
    mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity in dengue pathogenesis.
    Wan SW; Lin CF; Yeh TM; Liu CC; Liu HS; Wang S; Ling P; Anderson R; Lei HY; Lin YS
    J Formos Med Assoc; 2013 Jan; 112(1):3-11. PubMed ID: 23332423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.